Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.03.17.20037796: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Rabbit anti-fluorescein antibody (anti-FITC, 0.2 mg/ml, Abcam. Co., Ltd.), sheep anti-digoxigenin antibody (Anti-Dig, 0.25 mg/mL, Abcam. Co., Ltd.) and biotinylated bovine serum albumin (biotin-BSA, 4 mg/mL, Abcam. Co., Ltd.) were immobilized at detection regions (nitrocellulose membrane, NC) as the test line 1 (TL1), test line 2 (TL2) and control line (CL), respectively, with each line separated by 5 mm. anti-fluoresceinsuggested: Noneanti-FITCsuggested: Noneanti-digoxigeninsuggested: NoneA…SciScore for 10.1101/2020.03.17.20037796: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources Rabbit anti-fluorescein antibody (anti-FITC, 0.2 mg/ml, Abcam. Co., Ltd.), sheep anti-digoxigenin antibody (Anti-Dig, 0.25 mg/mL, Abcam. Co., Ltd.) and biotinylated bovine serum albumin (biotin-BSA, 4 mg/mL, Abcam. Co., Ltd.) were immobilized at detection regions (nitrocellulose membrane, NC) as the test line 1 (TL1), test line 2 (TL2) and control line (CL), respectively, with each line separated by 5 mm. anti-fluoresceinsuggested: Noneanti-FITCsuggested: Noneanti-digoxigeninsuggested: NoneAnti-Digsuggested: NoneTL2suggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-